2,6-Diaminopurine

2,6-Diaminopurine

SCHEMBL22775220

Nc1nc(N)c2[nH]cnc2n1.O=C1CCNC(=O)N1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.60
GDA Q9Y2T3 1/20 0.60
DPP4 P27487 1/20 0.47
CRBN Q96SW2 1/20 0.45
CDK2 P24941 10/20 0.43
MAP3K5 Q99683 1/20 0.40
MGMT P16455 6/20 0.40
PNP P00491 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
CDK1 P06493 9/20 0.38
CCNB1 P14635 9/20 0.38
CCNA2 P20248 9/20 0.38
CCNA1 P78396 9/20 0.38
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
PIN1 Q13526 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2,6-Diaminopurine SCHEMBL9220451 0.81 PDPK1 (0.64) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL22775219 0.79 CRBN (0.45) PDPK1GDACRBNADORA2A
2,6-Diaminopurine SCHEMBL24053 0.78 PDPK1 (1.00) PDPK1GDADPP4CDK2MAP3K5
SCHEMBL17200149 0.78 CRBN (0.41) DPP4CRBNPNPHRH4ADORA2A
2,6-Diaminopurine SCHEMBL8757979 0.76 PDPK1 (0.96) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL27891733 0.76 PDPK1 (0.96) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL28206545 0.76 PDPK1 (0.96) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL29143272 0.75 PDPK1 (0.92) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL160630 0.73 PDPK1 (0.52) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL4535059 0.72 PDPK1 (0.79) PDPK1GDADPP4CDK2MAP3K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983393-A1 NOVEL SPIROBICYCLIC INTERMEDIATES Janssen Pharmaceutica NV (BE) 2022-04-20 EP disclosed
WO-2020249663-A1 NOVEL SPIROBICYCLIC INTERMEDIATES JANSSEN PHARMACEUTICA NV (BE) 2020-12-17 WO disclosed